[go: up one dir, main page]

NO20043240L - Fremgangsmate for behandling av seksuelle dysfunksjoner med delta-opioidreseptoragonistforbindelse - Google Patents

Fremgangsmate for behandling av seksuelle dysfunksjoner med delta-opioidreseptoragonistforbindelse

Info

Publication number
NO20043240L
NO20043240L NO20043240A NO20043240A NO20043240L NO 20043240 L NO20043240 L NO 20043240L NO 20043240 A NO20043240 A NO 20043240A NO 20043240 A NO20043240 A NO 20043240A NO 20043240 L NO20043240 L NO 20043240L
Authority
NO
Norway
Prior art keywords
delta
receptor agonist
opioid receptor
agonist compound
treating sexual
Prior art date
Application number
NO20043240A
Other languages
English (en)
Inventor
William Pendergast
Kwen-Jen Chang
Jr Robert W Mcnutt
Klim King
Kestutis P Biciunas
Shyi-Tai Jan
Original Assignee
Ardent Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardent Pharmaceuticals Inc filed Critical Ardent Pharmaceuticals Inc
Publication of NO20043240L publication Critical patent/NO20043240L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20043240A 2002-01-02 2004-08-02 Fremgangsmate for behandling av seksuelle dysfunksjoner med delta-opioidreseptoragonistforbindelse NO20043240L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34521602P 2002-01-02 2002-01-02
PCT/US2003/000087 WO2003057223A1 (en) 2002-01-02 2003-01-02 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds

Publications (1)

Publication Number Publication Date
NO20043240L true NO20043240L (no) 2004-08-02

Family

ID=23354077

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043240A NO20043240L (no) 2002-01-02 2004-08-02 Fremgangsmate for behandling av seksuelle dysfunksjoner med delta-opioidreseptoragonistforbindelse

Country Status (7)

Country Link
US (6) US8575169B2 (no)
EP (1) EP1469850B1 (no)
AU (1) AU2003214800A1 (no)
NO (1) NO20043240L (no)
PL (1) PL372096A1 (no)
TW (1) TW200301701A (no)
WO (1) WO2003057223A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476280B2 (en) 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
AU2003291302A1 (en) * 2002-11-06 2004-06-03 Azaya Therapeutics, Inc. Method for treatment of premature ejaculation in humans
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
CN100549004C (zh) 2003-10-01 2009-10-14 阿得罗公司 螺环杂环衍生物及其应用方法
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CA2643677C (en) * 2005-04-14 2015-06-23 Mount Cook Biosciences, Inc. Compositions of novel opioid compounds and method of use thereof
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
US9365553B2 (en) 2010-05-27 2016-06-14 Aska Pharmaceutical Co., Ltd. Heterocyclic compound and H1 receptor antagonist
EP2968128A4 (en) * 2013-03-12 2016-11-16 Applied Biores Inc CHELATING COFFEE FOR IMPROVED DRUG DISPERSION
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations
EP3436013A4 (en) 2016-03-31 2019-11-13 Versi Group, LLC DELTA OPIOID AGONIST, MU OPIOID ANTAGONIST COMPOSITIONS AND METHOD FOR TREATING MORBUS PARKINSON
DE102017215686A1 (de) 2017-09-06 2019-03-07 Tridonic Gmbh & Co Kg Bewegungssensorvorrichtung, verfahren zum betreiben einer bewegungssensorvorrichtung und beleuchtungssystem

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453285A (en) 1967-11-29 1969-07-01 Miles Lab Tetrazolyl alkanoic acids
US5063929A (en) * 1989-08-25 1991-11-12 Staodyn, Inc. Electronic stimulating device having timed treatment of varying intensity and method therefor
US5151448A (en) * 1991-07-12 1992-09-29 Crenshaw Roger T Method for treating premature ejaculation
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US20020052007A1 (en) * 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5807858A (en) 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
EP0585500A1 (en) 1992-09-04 1994-03-09 Merrell Dow Pharmaceuticals Inc. Diaryl piperazineacetamides as antimuscarinic agents
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
RU2133744C1 (ru) 1993-07-30 1999-07-27 Дельта Фармасьютикалз, Инк. Пиперазиновые соединения
US5587167A (en) * 1993-09-14 1996-12-24 Choi; Hyung K. Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
IT1264965B1 (it) * 1993-11-12 1996-10-17 Giorgio Cavallini Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
JPH07247274A (ja) 1994-03-10 1995-09-26 Wakamoto Pharmaceut Co Ltd ピバル酸 テトラゾリルフェニルエステル誘導体、それらを有効成分として含有するエラスターゼ阻害剤及び肺障害治療剤
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
CN1128788C (zh) 1996-03-29 2003-11-26 辉瑞大药厂 苄基(亚苄基)-内酰胺衍生物,它们的制备以及作为5-ht1a和/或5-ht1d受体的选择性拮抗剂(激动剂)的用途
UA56185C2 (uk) * 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
EP0942728A1 (en) * 1996-12-02 1999-09-22 MERCK SHARP & DOHME LTD. Use of nk-1 receptor antagonists for treating sexual dysfunction
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
GB9709972D0 (en) 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001208D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0001207D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
US6974839B2 (en) 2001-03-16 2005-12-13 Dmi Biosciences, Inc. Method of delaying ejaculation

Also Published As

Publication number Publication date
EP1469850B1 (en) 2013-01-02
US20140031367A1 (en) 2014-01-30
US9296707B2 (en) 2016-03-29
US8575169B2 (en) 2013-11-05
AU2003214800A8 (en) 2003-07-24
US20130053326A9 (en) 2013-02-28
AU2003214800A1 (en) 2003-07-24
US20070173515A1 (en) 2007-07-26
PL372096A1 (en) 2005-07-11
TW200301701A (en) 2003-07-16
US20120220601A1 (en) 2012-08-30
WO2003057223A8 (en) 2004-07-29
WO2003057223A1 (en) 2003-07-17
US20150018372A1 (en) 2015-01-15
EP1469850A1 (en) 2004-10-27
WO2003057223A9 (en) 2004-04-29
EP1469850A4 (en) 2008-03-12
US20030186872A1 (en) 2003-10-02
US8865721B2 (en) 2014-10-21
US8551998B2 (en) 2013-10-08
US20160200689A1 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
DK1789433T3 (da) Fremgangsmåder til at behandle kutan rødmen med selektive alfa-2-adrenerge receptoragonister
NO20034575L (no) Apparat og fremgangsmate for boring med foring
DK1537291T3 (da) Borefremgangsmåde
NO20043240L (no) Fremgangsmate for behandling av seksuelle dysfunksjoner med delta-opioidreseptoragonistforbindelse
ITRM20030451A1 (it) Metodo e dispositivo per la rivelazione e la
NO20021119D0 (no) En installasjonsmetode
DE60324747D1 (de) Kabelbaum- Reichweiteverschiebungs- Vorhersagemethode,Vorhersage- Vorrichtung und Programm
FI20020547A7 (fi) Menetelmä ja laitteisto kokoonpanoon
DE60324018D1 (de) Agonisten
DE60224306D1 (de) Bohrvorrichtung für erdbohrer
FI20021643L (fi) Menetelmä pintajännityksen mittaamiseksi
AU2003243654A8 (en) Internal support apparatus for downhole tubular structures
FI20031658A0 (fi) Menetelmä ja laitteisto näytteiden tutkimiseksi massaspektrometrisesti
FI20020162L (fi) Menetelmä ja laite kuumaliimaukseen
FI20030380L (fi) Menetelmä prosessin säätämiseksi
FI20040745A0 (fi) Menetelmä ja asennusväline sähkökoneen asentamiseksi
EP1574531A4 (en) METHOD FOR DETERMINING TRACE METALS
AU2003233330A8 (en) Method for quantifying molecules
EP1576650A4 (en) METHOD OF MICRO-PRODUCING STRUCTURES USING SILICON-ON-ISOLATOR MATERIAL
AU2003227526A8 (en) Method for measuring thermal diffusity
FI20030381L (fi) Menetelmä prosessin säätämiseksi
DE602005014924D1 (de) Vibrations-Gleitschleifapparat
FI20030545A0 (fi) Poraukseen tarkoitettu kiinnityslaite
FI20020586A0 (fi) Menetelmä läpiporaukseen
FI20020952A0 (fi) Menetelmä eloperäisen materiaalin käsittelemiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application